Get notified when MCRB files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: MCRB Seres Therapeutics, Inc. 8-K

Seres trades $275M in future milestones for $25M cash, slashes office space 55% to save $34M

Filed June 5, 2026 · Period ending June 2, 2026 · ~1 min read

Key Changes

  • high

    Terminated $275M in future sales milestone payments from Nestlé in exchange for just $25M cash (paid in two installments by Oct 2026), converting uncertain future revenue into immediate liquidity at a 91% discount.

    Item 1.01: APA Amendment verify on EDGAR →
  • high

    Surrendered 55% of office and lab space (45,832 of 82,714 sq ft), saving $33.9M in total lease payments through 2036 but paying $7.7M in termination fees and allowing landlord to draw $6.3M letter of credit.

    Item 1.01: Lease Amendment verify on EDGAR →
  • medium

    Deferred eight months of rent (May-Dec 2026) into a $5.2M lump sum due January 2027, suggesting active near-term cash flow management alongside the milestone restructuring.

    Item 1.01: Lease Payment Terms verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.

Partner

Trade MCRB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify